Tweet I was into genetics very early on and was one of the first people to do a genome screens on mice to go gene hunting. They were closing the labs down where I was working and my boss wanted to keep the animal house open and we had our own animal technicians and so suggested…
Category: Multiple Sclerosis Research
Rituxiland can save more cash by less frequent dosing
Tweet Abstract Number: 59/O131RItuximab long-term DOSE trial in Multiple Sclerosis RItuximab long-term DOSE trial in Multiple Sclerosis – RIDOSE-MS. A phase 3 trial investigating extended RIDOSE-MS. A phase 3 trial investigating extended dosing regimen of rituximab in relapsing-remitting MS dosing regimen of rituximab in relapsing-remitting MS Anders Svenningsson Introduction: In the RIFUND-MS trial (NCT02746744), we…
Epic in-state journeys from baseball @ Comerica to lawmakers @ the Capitol
Some couples spend their weekends at home, catching up on to-do lists and binging shows on Netflix. But over the past few weeks, Dan and I have been racking up the miles across Michigan. From Dearborn to Detroit, Lansing to Ann Arbor, we’ve been on the road, with plenty of MS-related purpose along the way….
Another harrowing trip to the hospital
It makes you wonder when I’ll ever learn. Another trip to the ICU with dangerously low sodium or hyponytremia after a seizure at home might finally be enough to stop me from chugging gallons of water. Water is supposed to be good for you, right? But apparently there is too much of a good thing….
Turning 50 with MS feels like a new beginning
I celebrated my mid-century birthday two weeks ago with an online dance party with friends, family, and patients in “The Myelin Room” — a monthly Zoom event. At 50, I’ve […] The post Turning 50 with MS feels like a new beginning appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com
ECTRIMS 2025: Some older adults with MS may safely stop DMTs
Some older people with multiple sclerosis (MS), namely those older than 60, may be able to safely discontinue disease-modifying therapies (DMTs) as long as they continue to be regularly monitored […] The post ECTRIMS 2025: Some older adults with MS may safely stop DMTs appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com
ECTRIMS 2025: Stem cell transplant beats DMTs at lowering risk of PIRA
A stem cell transplant may offer better long-term results for people with aggressive multiple sclerosis (MS) compared with standard high-efficacy drug treatment, according to new evidence presented at a major […] The post ECTRIMS 2025: Stem cell transplant beats DMTs at lowering risk of PIRA appeared first on Multiple Sclerosis News Today. Source: multiplesclerosisnewstoday.com
Back to School Success
As the school year has officially started, going back to school can be stressful for some families. Students may be battling stresses associated with academic performance, peer pressure, social anxiety, etc. On the other hand, parents are anxiously hoping that … Continue reading → Source: blog.mymsaa.org
Remyelination Trial from UK. Top Line Result It was Positive.
Tweet The late breaker we have all been waiting for metformin and clemastin. It was presented a short while ago and it was positive in that the primary endpoint was met and there was improvement and.it was statistically positive…So this is great news. But the effect was not great. There was an increase in the…
DoDo is now offically a Dodo
Tweet ProfG suggested a two trials because he though the effect of ocrelizumab on progression could be due to antibody getting into the CNS and suggested a DOuble DOse the Dodo trial. The other trial was a watch an wait so treat for a while and then stop like you would with alemtuzumab and cladribine….